THE WHAT? Direct-to-consumer brand Bluebell has announced a US$20 million investment that will be used for new category and retail expansion.
THE DETAILS Bluebell was launched in 2019 and offers a tablet-based refill system to help eliminate single-use plastic.
The new round of financing was led by female-founded Prelude Growth Partners, a New York-based growth equity firm focused on consumer brands, and was funded by 95 percent female investors.
To date, the company has raised US$35 million from top industry leaders and celebrities including Justin Timberlake, Adrian Grenier, Jennifer Fleiss (Rent the Runway), Nicolas Jammet (Sweetgreen), and Nick Green (Thrive Market).
THE WHY? The latest round will accelerate Blueland’s direct-to-consumer and retail growth, fueling its continued expansion in the cleaning category and new entrance into personal care with ‘proprietary, high-performance and sustainable alternatives to everyday products in industries dominated by plastic packaging and harsh chemicals.’
Following the financial injection, Blueland aims to strengthen its investment in innovation and R&D and retail expansion.
Plans to expand into new cleaning and personal care category launches are already in place, with new offerings scheduled to debut in 2022.
Sarah Paiji Yoo, co-founder and CEO of Blueland, says, “”When we started Blueland, we set out to change both consumer behavior and industry practices around plastic consumption and production.
“We’ve seen tremendous positive reception as the first and leading brand to use no single-use plastic across all our cleaning products, and we are excited to expand into additional categories and channels and reach more consumers to maximize our impact on the planet.”
Aesthetic injectable companies refer to businesses or companies that specialize in manufacturing, distributing, or providing aesthetic injectable products and services. These companies focus on developing and supplying injectable substances used for cosmetic purposes, typically administered by qualified medical professionals. Aesthetic injectable companies play a crucial role in the field of aesthetic medicine and cosmetic dermatology by offering a variety of injectable products designed to enhance facial features, reduce wrinkles, and improve overall skin appearance.
Key aspects of aesthetic injectable companies include:
-
Product Development: These companies research, develop, and manufacture aesthetic injectables such as dermal fillers, botulinum toxins (e.g., Botox), collagen stimulators, and other specialized formulations. They often innovate new products to meet evolving market demands and technological advancements.
-
Distribution and Sales: Aesthetic injectable companies distribute their products through authorized channels, including healthcare providers, medical spas, and aesthetic clinics. They may also sell directly to licensed professionals who administer these treatments.
-
Regulatory Compliance: Due to the medical nature of their products, aesthetic injectable companies adhere to strict regulatory guidelines and obtain necessary approvals from health authorities (e.g., FDA in the United States) to ensure safety, efficacy, and quality standards.
-
Training and Support: Many companies provide training and educational support to healthcare professionals on the proper use, administration techniques, and safety protocols associated with their injectable products. This ensures that practitioners can deliver treatments effectively and safely.
-
Customer Support: Aesthetic injectable companies offer customer support services to healthcare providers and consumers, addressing inquiries, providing product information, and assisting with product usage and troubleshooting.
